Institute of Psychiatry, Psychology and Neuroscience
WHO urges US to ‘reconsider’ withdrawal from global health organisation
President Donald Trump said the agency mishandled the COVID-19 pandemic and other global health crises
WHO launches $1.5bn emergency appeal to tackle ongoing health crises
The appeal is aimed at providing urgent humanitarian assistance to more than 300 million people
WHO announces priority endemic pathogens for urgent vaccine development
The study identifies the 17 pathogens that regularly cause diseases in communities
Moderna’s JN.1-adapted COVID-19 vaccine approved by MHRA for adults and children
The JCVI has already advised the UK government on eligible groups for this year’s autumn vaccination programme
Novavax’s JN.1-adapted COVID-19 vaccine granted FDA emergency use authorisation
JN.1 only accounts for 0.2% of cases across the country but is the ‘parent strain’ of currently circulating variants
FDA approves updated COVID-19 vaccines to better protect against current variants
Adapted vaccines from Pfizer/BioNTech and Moderna have been authorised for individuals aged six months and older
WHO announces new mRNA vaccine development initiative against human avian influenza
H5N1 was responsible for 889 cases and 463 deaths across 23 countries from 2003 to 2024
JCVI announces advice for autumn COVID-19 vaccination programme eligibility
The Committee has advised offering the vaccine to those at high risk of serious disease
WHO and CEPI call for broader research strategy to prepare for future pandemics
They have highlighted the importance of expanding research to entire families of pathogens
WHO calls for better medicines access to close neurological disorders treatment gap
In 2021, neurological conditions affected more than three billion people worldwide
WHO publishes guidance for HPV vaccine developers to help tackle cervical cancer
In more than nine out of ten cases, the HPV virus leads to cervical cancer, the fourth most common cancer in women globally
WHO publishes new toolkit to improve services for neurological disorders
Neurological conditions such as dementia and stroke were responsible for more than three billion cases globally in 2021